Corrigendum to 'TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF' Journal of Investigative Dermatology, Volume 141, Issue 9, September 2021, Pages 2250-2260

Affiliations

¹ Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
² Ludwig Institute for Cancer Research, University of Oxford, Nuffield Department of Clinical Medicine, Oxford United Kingdom.
³ California Pacific Medical Center, Research Institute, San Francisco, California, USA.
⁴ IGDR (Institut de Génétique et Développement de Rennes) - UMR6290, CNRS, University of Rennes, Rennes, France; Department of Molecular Genetics and Genomics, Hospital University of Rennes (CHU Rennes), Rennes, France.

Published Erratum

Jade Peres et al. J Invest Dermatol. 2025 Oct.

. 2025 Oct;145(10):2647-2648.

doi: 10.1016/j.jid.2024.12.002. Epub 2025 May 21.

¹ Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
² Ludwig Institute for Cancer Research, University of Oxford, Nuffield Department of Clinical Medicine, Oxford United Kingdom.
³ California Pacific Medical Center, Research Institute, San Francisco, California, USA.
⁴ IGDR (Institut de Génétique et Développement de Rennes) - UMR6290, CNRS, University of Rennes, Rennes, France; Department of Molecular Genetics and Genomics, Hospital University of Rennes (CHU Rennes), Rennes, France.

No abstract available

Erratum for

TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
Peres J, Damerell V, Chauhan J, Popovic A, Desprez PY, Galibert MD, Goding CR, Prince S. Peres J, et al. J Invest Dermatol. 2021 Sep;141(9):2250-2260.e2. doi: 10.1016/j.jid.2021.02.740. Epub 2021 Mar 17. J Invest Dermatol. 2021. PMID: 33744299